Incorporating patient preferences into hospital quality metrics for heart failure

Adam D. DeVore; Karen E. Joynt Maddox

doi:10.1001/jamacardio.2020.4964

Incorporating patient preferences into hospital quality metrics for heart failure

Adam D. DeVore
, Karen E. Joynt Maddox

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	177-178
Number of pages	2
Journal	JAMA Cardiology
Volume	6
Issue number	2
DOIs	https://doi.org/10.1001/jamacardio.2020.4964
State	Published - Feb 2021

Access to Document

10.1001/jamacardio.2020.4964

Cite this

@article{3d3c0892e2c3446cb5fa4cdc1a49ac33,

title = "Incorporating patient preferences into hospital quality metrics for heart failure",

author = "DeVore, \{Adam D.\} and \{Joynt Maddox\}, \{Karen E.\}",

note = "Funding Information: reported receiving grants from the American Heart Association; Amgen; AstraZeneca; Bayer; Intra-Cellular Therapies; American Regent Inc; the National Heart, Lung, and Blood Institute; Novartis; and the Patient-Centered Outcomes Research Institute; personal fees from Amgen, AstraZeneca, Funding Information: Bayer, CareDx, InnaMed, LivaNova, Mardil Medical, Novartis, Procyrion, scPharmaceuticals, Story Health, and Zoll; and nonfinancial support from Abbott outside the submitted work. Dr Joynt Maddox reported receiving grants from the National Institute on Aging and the National Heart, Lung, and Blood Institute and financial support from the US Department of Health and Human Services outside the submitted work.",

year = "2021",

month = feb,

doi = "10.1001/jamacardio.2020.4964",

language = "English",

volume = "6",

pages = "177--178",

journal = "JAMA Cardiology",

issn = "2380-6583",

number = "2",

}

TY - JOUR

T1 - Incorporating patient preferences into hospital quality metrics for heart failure

AU - DeVore, Adam D.

AU - Joynt Maddox, Karen E.

N1 - Funding Information: reported receiving grants from the American Heart Association; Amgen; AstraZeneca; Bayer; Intra-Cellular Therapies; American Regent Inc; the National Heart, Lung, and Blood Institute; Novartis; and the Patient-Centered Outcomes Research Institute; personal fees from Amgen, AstraZeneca, Funding Information: Bayer, CareDx, InnaMed, LivaNova, Mardil Medical, Novartis, Procyrion, scPharmaceuticals, Story Health, and Zoll; and nonfinancial support from Abbott outside the submitted work. Dr Joynt Maddox reported receiving grants from the National Institute on Aging and the National Heart, Lung, and Blood Institute and financial support from the US Department of Health and Human Services outside the submitted work.

PY - 2021/2

Y1 - 2021/2

UR - https://www.scopus.com/pages/publications/85095826370

U2 - 10.1001/jamacardio.2020.4964

DO - 10.1001/jamacardio.2020.4964

M3 - Comment/debate

C2 - 33112367

AN - SCOPUS:85095826370

SN - 2380-6583

VL - 6

SP - 177

EP - 178

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 2

ER -

Incorporating patient preferences into hospital quality metrics for heart failure

Access to Document

Other files and links

Cite this